Shopping Cart
- Remove All
Your shopping cart is currently empty
Xanthine oxidoreductase-IN-3 is an orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 of 26.3 nM, suitable for use in acute hyperuricemia studies.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $109 | In Stock | |
| 5 mg | $270 | In Stock | |
| 10 mg | $383 | In Stock | |
| 25 mg | $575 | In Stock | |
| 50 mg | $783 | In Stock | |
| 100 mg | $1,070 | In Stock | |
| 200 mg | $1,450 | In Stock |
| Description | Xanthine oxidoreductase-IN-3 is an orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 of 26.3 nM, suitable for use in acute hyperuricemia studies. |
| Targets&IC50 | XOR:26.3 nM |
| In vivo | Xanthine oxidoreductase-IN-3 (compound IIIa) (5 mg/kg; oral) was shown to reduce uric acid in acute hyperuricemia mice 3 h after administration.[1] |
| Molecular Weight | 299.72 |
| Formula | C14H10ClN5O |
| Cas No. | 651769-78-7 |
| Smiles | C(NC1=CC=C(Cl)C=C1)(=O)C2=CC=C(C=C2)C=3NN=NN3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 45 mg/mL (150.14 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.